No recent analyst price targets found for BRRGF.
Latest News for BRRGF
Oncoinvent ASA: Second half 2025 results
OSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose, today announces its second half 2025 results. Oncoinvent's management team will give an online presentation to investors, analysts and the press at 09:30 CET today (details…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BRRGF.
Senate Trading
No Senate trades found for BRRGF.
U.S. House Trading
No House trades found for BRRGF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.